201 related articles for article (PubMed ID: 17634839)
21. [Splenic lymphoma with circulating villous lymphocytes. Study of 6 patients].
Batlle M; Ribera JM; Feliu E; Millá F; Sans-Sabrafén J; Villamor N; Marill N; Woessner S
Sangre (Barc); 1993 Aug; 38(4):267-71. PubMed ID: 8235939
[TBL] [Abstract][Full Text] [Related]
22. Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients. Groupe Francais d'Hématologie Cellulaire (GFHC).
Troussard X; Valensi F; Duchayne E; Garand R; Felman P; Tulliez M; Henry-Amar M; Bryon PA; Flandrin G
Br J Haematol; 1996 Jun; 93(3):731-6. PubMed ID: 8652403
[TBL] [Abstract][Full Text] [Related]
23. [Splenic lymphoma with villous lymphocytes. A clinical case].
Brambilla Pisoni G; Montalbetti L; Paparella P; Neri G
Minerva Med; 1997; 88(7-8):311-6. PubMed ID: 9304075
[TBL] [Abstract][Full Text] [Related]
24. Splenic marginal zone lymphoma.
Oscier D; Owen R; Johnson S
Blood Rev; 2005 Jan; 19(1):39-51. PubMed ID: 15572216
[TBL] [Abstract][Full Text] [Related]
25. Splenic B cell lymphoma with "villous" lymphocytes in the peripheral blood: a disorder distinct from hairy cell leukemia.
Melo JV; Robinson DS; Gregory C; Catovsky D
Leukemia; 1987 Apr; 1(4):294-8. PubMed ID: 3499540
[TBL] [Abstract][Full Text] [Related]
26. Splenic lymphoma with circulating villous lymphocytes: report of seven cases and review of the literature.
Sun T; Susin M; Brody J; Dittmar K; Teichberg S; Weiner R; Lin JH; Felber N
Am J Hematol; 1994 Jan; 45(1):39-50. PubMed ID: 8250010
[TBL] [Abstract][Full Text] [Related]
27. Splenic lymphoma with villous lymphocytes. Report of first 2 cases from the Middle East.
al-Bahar S; Pandita R; Dhabhar BN; al-Bahar E
Acta Haematol; 1993; 90(4):198-201. PubMed ID: 8140861
[TBL] [Abstract][Full Text] [Related]
28. Circulating villous lymphocytes--a link between hyperreactive malarial splenomegaly and splenic lymphoma.
Bates I; Bedu-Addo G; Rutherford TR; Bevan DH
Trans R Soc Trop Med Hyg; 1997; 91(2):171-4. PubMed ID: 9196759
[TBL] [Abstract][Full Text] [Related]
29. Splenic lymphoma with circulating villous lymphocytes.
Imbing F; Kumar D; Kumar S; Yuoh G; Gardner F
J Clin Pathol; 1995 Jun; 48(6):584-7. PubMed ID: 7665709
[TBL] [Abstract][Full Text] [Related]
30. Splenic marginal zone cell lymphoma. An immunophenotypic and molecular study of five cases.
Wu CD; Jackson CL; Medeiros LJ
Am J Clin Pathol; 1996 Mar; 105(3):277-85. PubMed ID: 8602607
[TBL] [Abstract][Full Text] [Related]
31. Establishment and characterization of a villous lymphoma cell line from splenic B-cell lymphoma.
Inokuchi K; Abo J; Takahashi H; Miyake K; Inokuchi S; Dan K; Nomura T
Leuk Res; 1995 Nov; 19(11):817-22. PubMed ID: 8551798
[TBL] [Abstract][Full Text] [Related]
32. Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d'Hématologie Cellulaire (GFHC) study.
Troussard X; Mauvieux L; Radford-Weiss I; Rack K; Valensi F; Garand R; Vekemans M; Flandrin G; Macintyre EA
Br J Haematol; 1998 Jun; 101(4):712-21. PubMed ID: 9674745
[TBL] [Abstract][Full Text] [Related]
33. Current approach to the biology and treatment of chronic lymphoid malignancies other than CLL.
Catovsky D
Hematol Cell Ther; 1996 Dec; 38 Suppl 2():S63-6. PubMed ID: 9137958
[TBL] [Abstract][Full Text] [Related]
34. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
35. Splenic marginal zone lymphoma: a distinctive type of low-grade B-cell lymphoma. A clinicopathological study of 13 cases.
Mollejo M; Menárguez J; Lloret E; Sánchez A; Campo E; Algara P; Cristóbal E; Sánchez E; Piris MA
Am J Surg Pathol; 1995 Oct; 19(10):1146-57. PubMed ID: 7573673
[TBL] [Abstract][Full Text] [Related]
36. Monoclonal lymphocytosis with villous lymphocytes: a chronic lymphoproliferative disease of CD11c+ B-cells.
Bassan R; Neonato MG; Abbate M; Motta T; Barbui T; Rambaldi A
Leukemia; 1991 Sep; 5(9):799-806. PubMed ID: 1682536
[TBL] [Abstract][Full Text] [Related]
37. Absence of cyclin D1 protein expression in splenic marginal zone lymphoma.
Savilo E; Campo E; Mollejo M; Pinyol M; Piris MA; Zukerberg LR; Yang WI; Koelliker DD; Nguyen PL; Harris NL
Mod Pathol; 1998 Jul; 11(7):601-6. PubMed ID: 9688179
[TBL] [Abstract][Full Text] [Related]
38. Lack of efficacy of 2-chlorodeoxyadenoside in the treatment of splenic lymphoma with villous lymphocytes.
Lefrère F; Hermine O; François S; Panelatti G; Valensi F; Grosbois B; Misset JL; Varet B; Troussard X
Leuk Lymphoma; 2000 Dec; 40(1-2):113-7. PubMed ID: 11426611
[TBL] [Abstract][Full Text] [Related]
39. The histopathology of splenic lymphoma with villous lymphocytes.
Isaacson PG; Matutes E; Burke M; Catovsky D
Blood; 1994 Dec; 84(11):3828-34. PubMed ID: 7949139
[TBL] [Abstract][Full Text] [Related]
40. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
